Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
586
datasets available to search
ShareScore release 0.9.0
Dataset results
586 results for “allogeneic stem cell transplant”
A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia
ClinicalTrials.gov study NCT01814488. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Escalation Antifungal Prophylaxis for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT04273178. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT03918343. IPD Sharing: NO. Countries: 1. Publications: 0.
Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT07003737. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD)
ClinicalTrials.gov study NCT01888458. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Condi
ClinicalTrials.gov study NCT03595800. IPD Sharing: NO. Countries: 1. Publications: 0.
Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms
ClinicalTrials.gov study NCT07148947. IPD Sharing: NO. Countries: 1. Publications: 0.
Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes (CTL) When Used for Prophylaxis Against CMV in Recipients of Allogeneic, T Cell Depleted Stem Cell Transplants
ClinicalTrials.gov study NCT00673868. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation
ClinicalTrials.gov study NCT00130754. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT04464889. IPD Sharing: NO. Countries: 1. Publications: 0.
Midostaurin in MRD (Minimal Residual Disease) Positive Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT03951961. IPD Sharing: NO. Countries: 1. Publications: 0.
Inspiratory Muscle Training in Patients Receiving Allogenic Stem Cell Transplantation
ClinicalTrials.gov study NCT01281410. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Study With Oral Panobinostat Maintenance Therapy Following Allogeneic Stem Cell Transplantation in Patients With High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01451268. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas
ClinicalTrials.gov study NCT02859402. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Opebacan in Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
ClinicalTrials.gov study NCT00454155. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT00674427. IPD Sharing: NO. Countries: 1. Publications: 0.
T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies
ClinicalTrials.gov study NCT00080925. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT01746849. IPD Sharing: Not stated. Countries: 1. Publications: 0.
T cell transcriptomes in the course of allogeneic hematopoietic stem cell transplantation II
GEO Series GSE158483. Homo sapiens. 102 samples. Type: Expression profiling by high throughput sequencing.
Addition of IL-6 inhibition to standard GVHD prophylaxis to prevent GVHD after allogeneic stem cell transplantation
GEO Series GSE61201. Homo sapiens. 47 samples. Type: Expression profiling by array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.